Aevi Genomic Medicine Inc. (GNMX) Dropped -7.52% or -0.17 To Price $2.09 On Thursday


Aevi Genomic Medicine Inc. (GNMX) dropped -7.52% or -0.17 to $2.09. It is close to 103093 shares traded, which is 78.49% compare to the average total volume 131340. The market cap of GNMX is $124.01 million. The year to date change is 82.26%. The 52 week price range is from $0.98 to $2.65. Price of GNMX have changed 11.33% during last week. It have changed 18.95% over last month, 83.74% over last 3 months, 77.95% over last 6 months and 17.10% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GNMX is 1.99. It is -4.78% below current price. The 200-day Moving Averages for GNMX is 1.49. It is -28.71% below current price. The 52-week High is 2.65. It is 26.79% from the current price. The 52-week Low is 0.98. It is -53.11% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GNMX is 3.02 on 2018-03-15. Short % to float is 0.78%. There are some statistics of GNMX. It is has market cap $124.01 million. The share outstanding is 59.34 million. The average volume is 131340. The percent of top 15 Institution holding is 47.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GNMX is -98.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GNMX is -85.68%.


Tags:

Share this post